Table 3.

ChR2-mCherry expression in cell bodies and axon terminals following VTA/SNc AAV injections in NOS1Cre-/+ mice

Group 1Group 2Group 3
Injection number78910131415161718
Cell bodies
VTAR+++++++++++++++++++
RLi++++++++++++
PBP++++++++++++++++++++++++++++
SNc+++++++++++++++++++++++++++
Axonal projections
Septum
MS++++++++
HDB++++
LS++++
ST++++
Striatum
NAc (shell)++++
VP++++++++++++
NAc (core)+
Hypothalamus
LH+++++++++++++++
DM+++++
PO++++++++
ZI++++
Thalamus
LHb++++
MD+
VM++++
Amygdala
EAM+
AA+
Midbrain
Mammillary+
Pons/medulla
DR+++++
PMnR+++++
MnR+++++++
PAG++++
CLi++++
NRO++++
  • ChR2-mCherry expression density: +, very sparse expression; ++, modest expression; +++, dense expression. AA, amygdaloid area; CLi, caudal linear nucleus; DM, dorsomedial hypothalamic nucleus; DR, dorsal raphe nucleus; EAM, extended amygdala, medial part; HDB, horizontal limb of the diagonal band of Broca; LH, lateral hypothalamus; LHb, lateral habenula; LS, lateral septum; MD, dorsomedial nucleus of the hypothalamus; Mm, mammillary bodies; MnR, median raphe nucleus; MS, medial septum; NAc, nucleus accumbens; NRO, nucleus raphe obscurus PAG, periaqueductal gray; PBP, parabrachial pigmented nucleus; PMnR, paramedian raphe nucleus; PO, preoptic area; RLi, rostral linear nucleus; SNr, substantia nigra pars reticulata; ST, stria terminalis; VM, ventromedial thalamus; VP, ventral pallidum; VTAR, rostral ventral tegmental area; ZI, zona inserta. a, cell bodies were restricted to the dorso-lateral boundary region of the VTAR and this was not seen in group 1 or group 3.